Is Ipamorelin safe?
Limited EvidenceSide effects, risks, and safety considerations based on available research.
Research status
Ipamorelin has very limited human safety data. Most information comes from animal studies, in vitro research, or anecdotal reports. This means the true risk profile in humans is largely unknown.
Known concerns & side effects
- ⚠not FDA approved for any indication
- ⚠most evidence comes from early-phase clinical trials that were not completed
- ⚠unregulated supply chain — quality and purity vary
- ⚠may cause headache, nausea, and water retention
- ⚠potential long-term risks of sustained GH elevation are unknown
Use caution with
Frequently asked questions
Is Ipamorelin safer than other growth hormone peptides?
Ipamorelin is considered one of the more selective GH secretagogues because it does not significantly raise cortisol or prolactin levels, unlike GHRP-6 or GHRP-2. However, it is still not FDA approved, and long-term safety data in humans is limited.
Full Ipamorelin Profile
Evidence, timeline, products & more
Take the Peptide Quiz
Get personalized recommendations
Last updated: 2025-03-21
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.